Items where Author is "Balermpas, Panagiotis"

Article

Haderlein, Marlen and von der Gruen, Jens and Balermpas, Panagiotis and Roedel, Claus and Hautmann, Matthias G. and Steger, Felix and Bohr, Christopher and Hehr, Thomas and Stromberger, Carmen and Budach, Volker and Schymalla, Markus and Engenhart-Cabillic, Rita and Kocik, Lukas and Geinitz, Hans and Nestle, Ursula and Klautke, Gunter and Scherl, Claudia and Gall, Christine and Frey, Benjamin and Schubert, Philipp and Semrau, Sabine and Ott, Oliver and Kesting, Marco and Iro, Heinrich and Mueller, Sarina K. and Fietkau, Rainer (2024) De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial). FRONTIERS IN ONCOLOGY, 14: 1447123. ISSN 2234-943X

Hecht, Markus and Eckstein, Markus and Rutzner, Sandra and von Der Grun, Jens and Illmer, Thomas and Klautke, Gunther and Laban, Simon and Hautmann, Matthias G. and Brunner, Thomas B. and Tamaskovics, Balint and Hinke, Axel and Zhou, Jian-Guo and Frey, Benjamin and Donaubauer, Anna-Jasmina and Becker, Ina and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2022) Induction chemoimmunotherapy followed by CD8+immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 10 (1): e003747. ISSN , 2051-1426

Semrau, Sabine and Gostian, Antoniu-Oreste and Traxdorf, Maximilian and Eckstein, Markus and Rutzner, Sandra and von der Grun, Jens and Illmer, Thomas and Hautmann, Matthias and Klautke, Gunther and Laban, Simon and Brunner, Thomas and Tamaskovics, Balint and Frey, Benjamin and Zhou, Jian-Guo and Geppert, Carol-Immanuel and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo and Iro, Heinrich and Fietkau, Rainer and Hecht, Markus (2021) Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer. CANCERS, 13 (8): 1959. ISSN , 2072-6694

Hecht, Markus and Hahn, Dennis and Wolber, Philipp and Hautmann, Matthias G. and Reichert, Dietmar and Weniger, Steffi and Belk, Claus and Bergmann, Tobias and Goehler, Thomas and Welslau, Manfred and Gross-Thie, Christina and Guntinas-Lichius, Orlando and von der Gruen, Jens and Balermpas, Panagiotis and Orlowski, Katrin and Messinger, Diethelm and Stenzel, Karsten G. and Fietkau, Rainer (2021) A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer. CANCERS, 13 (14): 3413. ISSN , 2072-6694

Hecht, Markus and Gostian, Antoniu Oreste and Eckstein, Markus and Rutzner, Sandra and von der Gruen, Jens and Illmer, Thomas and Hautmann, Matthias G. and Klautke, Gunther and Laban, Simon and Brunner, Thomas and Hinke, Axel and Becker, Ina and Frey, Benjamin and Semrau, Sabine and Geppert, Carol and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Fietkau, Rainer (2020) Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (2): e001378. ISSN 2051-1426

Hecht, Markus and Hahn, Dennis and Wolber, Philipp and Hautmann, Matthias G. and Reichert, Dietmar and Weniger, Steffi and Belka, Claus and Bergmann, Tobias and Goehler, Thomas and Welslau, Manfred and Grosse-Thie, Christina and Guntinas-Lichius, Orlando and von der Gruen, Jens and Balermpas, Panagiotis and Orlowski, Katrin and Messinger, Diethelm and Stenzel, Karsten G. and Fietkau, Rainer (2020) Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer. BMC CANCER, 20 (1): 933. ISSN 1471-2407

Conference or Workshop Item

Hecht, Markus and Eckstein, Markus and Kallies, Annett and Klautke, Gunther and Illmer, Thomas and Von der Gruen, Jens and Laban, Simon and Hautmann, Matthias G. and Tamaskovics, Balint and Brunner, Thomas and Hinke, Axel and Frey, Benjamin and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2022) Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 03-07, 2022, Elec Network.

Hecht, Markus and Eckstein, Markus and Kallies, Annett and Von der Grün, Jens and Illmer, Thomas and Klautke, Gunther and Laban, Simon and Hautmann, Matthias and Brunner, Thomas and Tamaskovics, Balint and Hinke, Axel and Zhou, Jian-Guo and Frey, Benjamin and Donaubauer, Anna-Jasmina and Becker, Ina and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2022) Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Hecht, Markus and Eckstein, Markus and Rutzner, Sandra and von der Gruen, Jens and Illmer, Thomas and Klautke, Gunther and Laban, Simon and Hautmann, Matthias G. and Brunner, Thomas and Tamaskovics, Balint and Hinke, Axel and Frey, Benjamin and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2021) Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. In: 2021 ASCO Annual Meeting, 4. Juni - 8. Juni 2021, Online.